Drug Shortage Report for HYZAAR
Report ID | 71160 |
Drug Identification Number | 02230047 |
Brand name | HYZAAR 50/12.5MG |
Common or Proper name | losartan potassium and hydrochlorothiazide tablets |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Pack of 30 tablets |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-01-23 |
Actual start date | 2019-01-23 |
Estimated end date | 2019-04-19 |
Actual end date | 2019-04-15 |
Shortage status | Resolved |
Updated date | 2019-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-03 | English | Compare |